Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Breaching the barrier

Nature Biotechnology volume 26, pages 1213–1215 (2008)Cite this article

The blood-brain barrier has confounded the development of many neurological treatments over the years. Now, several companies are claiming they can tackle the problem. Alan Dove reports.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Springfield, Massachusetts

    Alan Dove

Authors
  1. Alan Dove
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dove, A. Breaching the barrier. Nat Biotechnol 26, 1213–1215 (2008). https://doi.org/10.1038/nbt1108-1213

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1108-1213

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing